System Alert
Skip to Main Content

HRSA Electronic Handbooks

Collapse Top Navigation

Funding Cycle View


Sickle Cell Disease Treatment Demonstration Program Regional Collaborative

  • Program Name:Sickle Cell Treatment Demonstration Program
  • Activity Code:U1E
  • Application Available:4/24/2014
  • Application Deadline:5/30/2014
  • Created By:Diener, Carrie
  • Created On:5/17/2013
  • Last Updated by:User, Administrator
  • Last Updated On:1/30/2015
  • Estimated Project Start Date:9/1/2014

 Details of the changes posted in this announcement

Modification published on 01/30/2015
Modified April 25, 2014: New Policy Requirement Added Regarding Federal Recognition of Same-sex Spouses/Marriages Language

Modification published on 01/30/2015
Deadline extended only for those applicants with a previoiusly approved waiver from HRSA's Division of Grants Policy.


 Announcement Information

Announcement Number HRSA-14-078
Announcement Code
CFDA Number 93.365
Provisional No
Activity Code U1E
Competitive Yes
Fiscal Year 2014


This announcement solicits applications for the Sickle Cell Treatment Demonstration Program Regional Collaborative.  The purpose of this funding opportunity is to: (1) increase the number of providers that are treating sickle cell patients in the region; (2) increase the number of providers prescribing disease-modifying therapies, such as hydroxyrea; and (3) increase the number of sickle cell patients that are receiving care from providers with greater knowledge of how to treat sickle cell disease.  This program will use collective impact strategies (see Collective Impact below) and collaborative learning to create Sickle Cell Regional Collaboratives that develop regional and sstate infrastructure to increase the number of providers providing disease-modifying therapies and enhancing the prevention and treatment of sickle cell disease through coordination of service delivery, genetic counseling and testing, bundling of technical services, training of health professionals, and efforts related to the expansion and coordination of education, treatment, and continuity of care for individuals with sickle cell disease.

 Legislative Information

American Jobs Creation Act of 2004, P.L. 108-357, Title VII, § 712(c) (42 U.S.C. 300b–1)

 Application Information

Application Available 04/24/2014
Application Deadline 05/30/2014
Supplemental Application Deadline N/A
Explanation for Deadline N/A
Archive Date 07/26/2014
Letter of Intent Not required
Application Package SF424
FOA Available Yes
Competitive Application Types Supported New
Allow Electronic Submission N/A
Page Limit for Application
Allow Multiple Applications
from an Organization from
Electronic Submission Instruction Electronic submission is/will be available in Grants.Gov

 General Information

Projected Award Date N/A
Estimated Project Period N/A
Estimated Project Start Date 09/01/2014
Estimated Project End Date 08/31/2017
Estimated Amount of this Competition $3,400,000.00
Estimated Number of Awards 4
Estimated Average Size of Awards $850,000.00
Cost Sharing No
Cooperative Agreement Yes

 Contact Information

Name Edward Donnell Ivy, M.D., M.P.H.
Phone Number 301 443-9775

 Download Information

Expand FOA (Guidance) Attachment (Minimum 0) (Maximum 1)
Document Name Size Date Attached Description
HRSA-14-078 Final 4-25-14.pdf 221 kB 04/25/2014
Expand Application Package (Minimum 0) (Maximum 1)
No documents attached
Expand User Guide (Minimum 0) (Maximum 1)
No documents attached

Scroll to top

Tools Panel